CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer

Published:2021-07 Issue: Volume: Page:
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

De Ruysscher Dirk,Ramalingam Suresh,Urbanic James,Gerber David E,Tan Daniel S.W.,Cai Junliang,Li Ang,Peters Solange

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

2. Long-term results of NRG oncology RTOG 0617 standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer;Bradley;J Clin Oncol,2020

3. Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer;Melosky;Lung Cancer,2019

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

5. 5-year survival outcomes with durvalumab after chemotherapy in unresectable stage III NSCLC - an update from the PACIFIC trial;Spigel;J Clin Oncol,2021

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calls to action on lung cancer management and research;The Oncologist;2024-07-13

2. Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy;Clinical Lung Cancer;2024-07

3. A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer;Journal of Clinical Medicine;2024-04-30

4. The role of chemoradiotherapy and immunotherapy in stage III NSCLC;Pathology and Oncology Research;2024-04-19

5. Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11